Targeting REGNASE-1 programs long-lived effector T cells for cancer therapyJun Wei, Hongbo Chi, Hongling Huang et al.|Nature|2019Cited by 445
Lipid signalling enforces functional specialization of Treg cells in tumoursSeon Ah Lim, Hongbo Chi, Jun Wei et al.|Nature|2021Cited by 422
SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunityChuansheng Guo, Hongbo Chi, Zhiyuan You et al.|Nature|2023Cited by 289
Single-cell CRISPR screens in vivo map T cell fate regulomes in cancerPeipei Zhou, Hongbo Chi, Hao Shi et al.|Nature|2023Cited by 165
In vivo CRISPR screening reveals nutrient signaling processes underpinning CD8+ T cell fate decisionsHongling Huang, Hongbo Chi, Peipei Zhou et al.|Cell|2021Cited by 153